Clinical Trial Update: A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 [Phase 4]

View source ↗

Summary

Phase 4 trial updating human T cell responses to live attenuated Japanese Encephalitis vaccine SA14-14-2; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• Japanese Encephalitis Vaccine SA14-14-2 (live attenuated Japanese Encephalitis vaccine SA14-14-2)

Snippet

Sponsor: Indian Institute of Science | Conditions: Japanese Encephalitis, Japanese Encephalitis Vaccine | Phase 4 | Status: COMPLETED | Results posted: 2019-04-26